These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 9752316)
1. [Chromosome translocations and leukemias induced by inhibitors of topoisomerase II anticarcinogenic drugs]. Dassonneville L; Bailly C Bull Cancer; 1998 Mar; 85(3):254-61. PubMed ID: 9752316 [TBL] [Abstract][Full Text] [Related]
2. Chromosomal abnormalities in secondary MDS and AML. Relationship to drugs and radiation with specific emphasis on the balanced rearrangements. Andersen MK; Johansson B; Larsen SO; Pedersen-Bjergaard J Haematologica; 1998 Jun; 83(6):483-8. PubMed ID: 9676019 [TBL] [Abstract][Full Text] [Related]
3. ALL-1 gene rearrangements in DNA topoisomerase II inhibitor-related leukemia in children. Felix CA; Hosler MR; Winick NJ; Masterson M; Wilson AE; Lange BJ Blood; 1995 Jun; 85(11):3250-6. PubMed ID: 7756657 [TBL] [Abstract][Full Text] [Related]
4. Cytogenetic and molecular analysis of MLL rearrangements in acute lymphoblastic leukaemia survivors. Brassesco MS; Montaldi AP; Gras DE; Camparoto ML; Martinez-Rossi NM; Scrideli CA; Tone LG; Sakamoto-Hojo ET Mutagenesis; 2009 Mar; 24(2):153-60. PubMed ID: 19028982 [TBL] [Abstract][Full Text] [Related]
5. 11q23 aberration is an additional chromosomal change in de novo acute leukemia after treatment with etoposide and mitoxantrone. Ohshima A; Miura I; Chubachi A; Hashimoto K; Nimura T; Utsumi S; Takahashi N; Hayashi Y; Seto M; Ueda R; Miura AB Am J Hematol; 1996 Dec; 53(4):264-6. PubMed ID: 8948668 [TBL] [Abstract][Full Text] [Related]
6. Rearrangements of the MLL gene in therapy-related acute myeloid leukemia in patients previously treated with agents targeting DNA-topoisomerase II. Super HJ; McCabe NR; Thirman MJ; Larson RA; Le Beau MM; Pedersen-Bjergaard J; Philip P; Diaz MO; Rowley JD Blood; 1993 Dec; 82(12):3705-11. PubMed ID: 8260707 [TBL] [Abstract][Full Text] [Related]
10. Leukemia in infants. Felix CA; Lange BJ Oncologist; 1999; 4(3):225-40. PubMed ID: 10394590 [TBL] [Abstract][Full Text] [Related]
11. Therapy-related myelodysplasia and acute myeloid leukemia. Cytogenetic characteristics of 115 consecutive cases and risk in seven cohorts of patients treated intensively for malignant diseases in the Copenhagen series. Pedersen-Bjergaard J; Philip P; Larsen SO; Andersson M; Daugaard G; Ersbøll J; Hansen SW; Hou-Jensen K; Nielsen D; Sigsgaard TC Leukemia; 1993 Dec; 7(12):1975-86. PubMed ID: 8255096 [TBL] [Abstract][Full Text] [Related]
12. Secondary leukemias induced by topoisomerase-targeted drugs. Felix CA Biochim Biophys Acta; 1998 Oct; 1400(1-3):233-55. PubMed ID: 9748598 [TBL] [Abstract][Full Text] [Related]
13. DNA topoisomerase II in therapy-related acute promyelocytic leukemia. Mistry AR; Felix CA; Whitmarsh RJ; Mason A; Reiter A; Cassinat B; Parry A; Walz C; Wiemels JL; Segal MR; Adès L; Blair IA; Osheroff N; Peniket AJ; Lafage-Pochitaloff M; Cross NC; Chomienne C; Solomon E; Fenaux P; Grimwade D N Engl J Med; 2005 Apr; 352(15):1529-38. PubMed ID: 15829534 [TBL] [Abstract][Full Text] [Related]
14. Common region of ALL-1 gene disrupted in epipodophyllotoxin-related secondary acute myeloid leukemia. Felix CA; Winick NJ; Negrini M; Bowman WP; Croce CM; Lange BJ Cancer Res; 1993 Jul; 53(13):2954-6. PubMed ID: 8319201 [TBL] [Abstract][Full Text] [Related]
15. Predisposition to therapy-related acute leukemia with balanced chromosomal translocations does not result from a major constitutive defect in DNA double-strand break end joining. Coiteux V; Onclercq-Delic R; Fenaux P; Amor-Guéret M Leuk Res; 2007 Mar; 31(3):353-8. PubMed ID: 16890283 [TBL] [Abstract][Full Text] [Related]
16. Inversion of chromosome 11 inv(11)(p15q22), as a recurring chromosomal aberration associated with de novo and secondary myeloid malignancies: identification of a P1 clone spanning the 11q22 breakpoint. Kobayashi H; Arai Y; Hosoda F; Maseki N; Hayashi Y; Eguchi H; Ohki M; Kaneko Y Genes Chromosomes Cancer; 1997 Jul; 19(3):150-5. PubMed ID: 9218995 [TBL] [Abstract][Full Text] [Related]
17. Therapy-related acute leukemia associated with involvement of 11q23 after high grade non-Hodgkin lymphoma. Martinelli G; Testoni N; Zinzani PL; Biondi A; Cimino G; Tura S Haematologica; 1998 Mar; 83(3):283-4. PubMed ID: 9573684 [TBL] [Abstract][Full Text] [Related]
18. Near-precise interchromosomal recombination and functional DNA topoisomerase II cleavage sites at MLL and AF-4 genomic breakpoints in treatment-related acute lymphoblastic leukemia with t(4;11) translocation. Lovett BD; Lo Nigro L; Rappaport EF; Blair IA; Osheroff N; Zheng N; Megonigal MD; Williams WR; Nowell PC; Felix CA Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9802-7. PubMed ID: 11493704 [TBL] [Abstract][Full Text] [Related]
19. HRX involvement in de novo and secondary leukemias with diverse chromosome 11q23 abnormalities. Hunger SP; Tkachuk DC; Amylon MD; Link MP; Carroll AJ; Welborn JL; Willman CL; Cleary ML Blood; 1993 Jun; 81(12):3197-203. PubMed ID: 8389614 [TBL] [Abstract][Full Text] [Related]
20. Secondary acute myelogenous leukemia and myelodysplasia without abnormalities of chromosome 11q23 following treatment of acute leukemia with topoisomerase II-based chemotherapy. Seiter K; Feldman EJ; Sreekantaiah C; Pozzuoli M; Weisberger J; Liu D; Papageorgio C; Weiss M; Kancherla R; Ahmed T Leukemia; 2001 Jun; 15(6):963-70. PubMed ID: 11417484 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]